{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:34:04Z","timestamp":1792650844261,"version":"4.5.0"},"reference-count":203,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.metabol.2018.10.005","type":"journal-article","created":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T17:34:57Z","timestamp":1539884097000},"page":"1-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":122,"special_numbering":"C","title":["Stem cells in the treatment of diabetes mellitus \u2014 Focus on mesenchymal stem cells"],"prefix":"10.1016","volume":"90","author":[{"given":"G\u00fcnter","family":"P\u00e4th","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Perakakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Seufert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2018.10.005_bb0005","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.metabol.2016.05.016","article-title":"Immune therapy in type 1 diabetes mellitus \u2014 attempts to untie the Gordian knot?","volume":"65","author":"Perakakis","year":"2016","journal-title":"Metab Clin Exp"},{"key":"10.1016\/j.metabol.2018.10.005_bb0010","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/MOT.0000000000000546","article-title":"Clinical islet transplantation: is the future finally now?","volume":"23","author":"Pepper","year":"2018","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.metabol.2018.10.005_bb0015","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM200007273430401","article-title":"Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen","volume":"343","author":"Shapiro","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2018.10.005_bb0020","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/j.1600-6143.2011.03977.x","article-title":"Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes","volume":"12","author":"Bellin","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.metabol.2018.10.005_bb0025","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.2337\/db16-0234","article-title":"National Institutes of Health\u2014sponsored clinical islet transplantation consortium phase 3 trial: manufacture of a complex cellular product at eight processing facilities","volume":"65","author":"Ricordi","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2018.10.005_bb0030","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nrendo.2016.178","article-title":"Clinical pancreatic islet transplantation","volume":"13","author":"Shapiro","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.metabol.2018.10.005_bb0035","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1016\/j.transproceed.2014.06.006","article-title":"Long-term outcomes of clinical transplantation of pancreatic islets with uncontrolled donors after cardiac death: a multicenter experience in Japan","volume":"46","author":"Anazawa","year":"2014","journal-title":"Transplant Proc"},{"key":"10.1016\/j.metabol.2018.10.005_bb0040","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.2337\/dc15-1988","article-title":"Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia","volume":"39","author":"Hering","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2018.10.005_bb0045","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1097\/TP.0000000000001381","article-title":"Islet transplantation provides superior glycemic control with less hypoglycemia compared with continuous subcutaneous insulin infusion or multiple daily insulin injections","volume":"101","author":"Holmes-Walker","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.metabol.2018.10.005_bb0050","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1097\/TP.0b013e318190b052","article-title":"A multi-year analysis of islet transplantation compared with intensive medical therapy on progression of complications in type 1 diabetes","volume":"86","author":"Warnock","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.metabol.2018.10.005_bb0055","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/TP.0000000000000288","article-title":"Has the gap between pancreas and islet transplantation closed?","volume":"98","author":"Niclauss","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.metabol.2018.10.005_bb0060","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2337\/diabetes.54.7.2060","article-title":"Five-year follow-up after clinical islet transplantation","volume":"54","author":"Ryan","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2018.10.005_bb0065","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/MOT.0b013e32834ee700","article-title":"Long-term outcome after pancreas transplantation","volume":"17","author":"Gruessner","year":"2012","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.metabol.2018.10.005_bb0070","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/nm.3267","article-title":"Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies","volume":"19","author":"Lee","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2018.10.005_bb0075","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3390\/jcm4010159","article-title":"Design of a tumorigenicity test for induced pluripotent stem cell (iPSC)-derived cell products","volume":"4","author":"Kawamata","year":"2015","journal-title":"Journal of clinical medicine"},{"key":"10.1016\/j.metabol.2018.10.005_bb0080","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/nbt1259","article-title":"Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells","volume":"24","author":"D'Amour","year":"2006","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.metabol.2018.10.005_bb0085","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cell.2014.09.040","article-title":"Generation of functional human pancreatic beta cells in vitro","volume":"159","author":"Pagliuca","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2018.10.005_bb0090","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.5966\/sctm.2015-0079","article-title":"Insulin-producing endocrine cells differentiated in vitro from human embryonic stem cells function in macroencapsulation devices in vivo","volume":"4","author":"Agulnick","year":"2015","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.metabol.2018.10.005_bb0095","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/nbt.3033","article-title":"Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells","volume":"32","author":"Rezania","year":"2014","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.metabol.2018.10.005_bb0100","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.bbrc.2017.04.062","article-title":"Closed-channel culture system for efficient and reproducible differentiation of human pluripotent stem cells into islet cells","volume":"487","author":"Hirano","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2018.10.005_bb0105","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1007\/s001250100012","article-title":"Blood glucose normalization upon transplantation of human embryonic pancreas into beta-cell-deficient SCID mice","volume":"44","author":"Castaing","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2018.10.005_bb0110","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nbt1393","article-title":"Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo","volume":"26","author":"Kroon","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.metabol.2018.10.005_bb0115","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.2337\/db11-1711","article-title":"Maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice","volume":"61","author":"Rezania","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2018.10.005_bb0120","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1002\/stem.1489","article-title":"Enrichment of human embryonic stem cell-derived NKX6.1-expressing pancreatic progenitor cells accelerates the maturation of insulin-secreting cells in vivo","volume":"31","author":"Rezania","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.metabol.2018.10.005_bb0125","doi-asserted-by":"crossref","first-page":"927","DOI":"10.5966\/sctm.2015-0058","article-title":"Concise review: manufacturing of pancreatic endoderm cells for clinical trials in type 1 diabetes","volume":"4","author":"Schulz","year":"2015","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.metabol.2018.10.005_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037004","article-title":"A scalable system for production of functional pancreatic progenitors from human embryonic stem cells","volume":"7","author":"Schulz","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2018.10.005_bb0135","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1097\/TP.0000000000001146","article-title":"Assessment of immune isolation of allogeneic mouse pancreatic progenitor cells by a macroencapsulation device","volume":"100","author":"Faleo","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.metabol.2018.10.005_bb0140","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.scr.2014.03.003","article-title":"Human embryonic stem cell derived islet progenitors mature inside an encapsulation device without evidence of increased biomass or cell escape","volume":"12","author":"Kirk","year":"2014","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.metabol.2018.10.005_bb0145","first-page":"622","article-title":"The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles","volume":"10","author":"Gurdon","year":"1962","journal-title":"J Embryol Exp Morpholog"},{"key":"10.1016\/j.metabol.2018.10.005_bb0150","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/385810a0","article-title":"Viable offspring derived from fetal and adult mammalian cells","volume":"385","author":"Wilmut","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2018.10.005_bb0155","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2018.10.005_bb0160","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.stem.2009.05.005","article-title":"Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins","volume":"4","author":"Kim","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.metabol.2018.10.005_bb0165","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s13238-013-3074-1","article-title":"Toward pluripotency by reprogramming: mechanisms and application","volume":"4","author":"Wang","year":"2013","journal-title":"Protein Cell"},{"key":"10.1016\/j.metabol.2018.10.005_bb0170","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/jmcb\/mju029","article-title":"Generation of insulin-producing beta-like cells from human iPS cells in a defined and completely xeno-free culture system","volume":"6","author":"Shahjalal","year":"2014","journal-title":"J Mol Cell Biol"},{"key":"10.1016\/j.metabol.2018.10.005_bb0175","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/1753-0407.12400","article-title":"Efficient generation of functional pancreatic beta-cells from human induced pluripotent stem cells","volume":"9","author":"Yabe","year":"2017","journal-title":"J Diabetes"},{"key":"10.1016\/j.metabol.2018.10.005_bb0180","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1002\/term.2228","article-title":"Production of pancreatic progenitor cells from human induced pluripotent stem cells using a three-dimensional suspension bioreactor system","volume":"11","author":"Mihara","year":"2017","journal-title":"J Tissue Eng Regen Med"},{"key":"10.1016\/j.metabol.2018.10.005_bb0185","doi-asserted-by":"crossref","first-page":"35908","DOI":"10.1038\/srep35908","article-title":"An inhibitor of fibroblast growth factor receptor-1 (FGFR1) promotes late-stage terminal differentiation from NGN3+ pancreatic endocrine progenitors","volume":"6","author":"Yamashita-Sugahara","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2018.10.005_bb0190","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/ncb2239","article-title":"Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells","volume":"13","author":"Ohi","year":"2011","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.metabol.2018.10.005_bb0195","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/471046a","article-title":"Stem cells: the dark side of induced pluripotency","volume":"471","author":"Pera","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2018.10.005_bb0200","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11886-017-0842-1","article-title":"Untangling the biology of genetic cardiomyopathies with pluripotent stem cell disease models","volume":"19","author":"Buikema","year":"2017","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.metabol.2018.10.005_bb0205","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00109-017-1533-5","article-title":"Induced pluripotent stem cell-based modeling of neurodegenerative diseases: a focus on autophagy","volume":"95","author":"Jungverdorben","year":"2017","journal-title":"J Mol Med"},{"key":"10.1016\/j.metabol.2018.10.005_bb0210","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.gde.2012.05.005","article-title":"New lessons learned from disease modeling with induced pluripotent stem cells","volume":"22","author":"Onder","year":"2012","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.metabol.2018.10.005_bb0215","article-title":"Roles for mesenchymal stem cells as medicinal signaling cells","volume":"11","author":"Somoza","year":"2016","journal-title":"Nat Protoc"},{"key":"10.1016\/j.metabol.2018.10.005_bb0220","first-page":"393","article-title":"The development of fibroblast colonies in monolayer cultures of Guinea-pig bone marrow and spleen cells","volume":"3","author":"Friedenstein","year":"1970","journal-title":"Cell Tissue Kinet"},{"key":"10.1016\/j.metabol.2018.10.005_bb0225","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00007890-197404000-00001","article-title":"Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo","volume":"17","author":"Friedenstein","year":"1974","journal-title":"Transplantation"},{"key":"10.1016\/j.metabol.2018.10.005_bb0230","first-page":"267","article-title":"Fibroblast precursors in normal and irradiated mouse hematopoietic organs","volume":"4","author":"Friedenstein","year":"1976","journal-title":"Exp Hematol"},{"key":"10.1016\/j.metabol.2018.10.005_bb0235","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1126\/science.161.3836.54","article-title":"Transplantation of marrow to extramedullary sites","volume":"161","author":"Tavassoli","year":"1968","journal-title":"Science"},{"key":"10.1016\/j.metabol.2018.10.005_bb0240","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jor.1100090504","article-title":"Mesenchymal stem cells","volume":"9","author":"Caplan","year":"1991","journal-title":"J Orthop Res"},{"key":"10.1016\/j.metabol.2018.10.005_bb0245","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/jor.23560","article-title":"New MSC: MSCs as pericytes are Ssentinels and gatekeepers","volume":"35","author":"Caplan","year":"2017","journal-title":"J Orthop Res"},{"key":"10.1016\/j.metabol.2018.10.005_bb0250","series-title":"Musculoskeletal soft-tissue aging: impact on mobility","first-page":"79","article-title":"Diminution of the number of mesenchymal stem cells as a cause for skeletal aging","author":"Haynesworth","year":"1994"},{"key":"10.1016\/j.metabol.2018.10.005_bb0255","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1089\/hum.1997.8.12-1417","article-title":"LacZ and interleukin-3 expression in vivo after retroviral transduction of marrow-derived human osteogenic mesenchymal progenitors","volume":"8","author":"Allay","year":"1997","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.metabol.2018.10.005_bb0260","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3109\/17453678909149289","article-title":"Repair of bone defects with marrow cells and porous ceramic. Experiments in rats","volume":"60","author":"Ohgushi","year":"1989","journal-title":"Acta Orthop Scand"},{"key":"10.1016\/j.metabol.2018.10.005_bb0265","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJM200102013440516","article-title":"Repair of large bone defects with the use of autologous bone marrow stromal cells","volume":"344","author":"Quarto","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2018.10.005_bb0270","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.cell.2007.08.025","article-title":"Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment","volume":"131","author":"Sacchetti","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2018.10.005_bb0275","first-page":"7","article-title":"The relationship between the spleen colony-forming cell and the haemopoietic stem cell","volume":"4","author":"Schofield","year":"1978","journal-title":"Blood Cells"},{"key":"10.1016\/j.metabol.2018.10.005_bb0280","first-page":"557","article-title":"Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use","volume":"16","author":"Lazarus","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.metabol.2018.10.005_bb0285","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12185-017-2262-9","article-title":"Complexity of bone marrow hematopoietic stem cell niche","volume":"106","author":"Asada","year":"2017","journal-title":"Int J Hematol"},{"key":"10.1016\/j.metabol.2018.10.005_bb0290","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/stem.2711","article-title":"Concise review: conceptualizing paralogous stem-cell niches and unfolding bone marrow progenitor cell identities","volume":"36","author":"Chen","year":"2018","journal-title":"Stem Cells"},{"key":"10.1016\/j.metabol.2018.10.005_bb0295","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1182\/blood-2004-11-4422","article-title":"Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells","volume":"106","author":"Nilsson","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.metabol.2018.10.005_bb0300","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.stem.2016.07.004","article-title":"Proximity-based differential single-cell analysis of the niche to identify stem\/progenitor cell regulators","volume":"19","author":"Silberstein","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.metabol.2018.10.005_bb0305","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nature12612","article-title":"Arteriolar niches maintain haematopoietic stem cell quiescence","volume":"502","author":"Kunisaki","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2018.10.005_bb0310","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nature09262","article-title":"Mesenchymal and haematopoietic stem cells form a unique bone marrow niche","volume":"466","author":"Mendez-Ferrer","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2018.10.005_bb0315","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nature06685","article-title":"Haematopoietic stem cell release is regulated by circadian oscillations","volume":"452","author":"Mendez-Ferrer","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2018.10.005_bb0320","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.stem.2014.06.008","article-title":"Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow","volume":"15","author":"Zhou","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.metabol.2018.10.005_bb0325","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1101\/gad.311068.117","article-title":"Stem cell niche-specific Ebf3 maintains the bone marrow cavity","volume":"32","author":"Seike","year":"2018","journal-title":"Genes Dev"},{"key":"10.1016\/j.metabol.2018.10.005_bb0330","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.stem.2008.07.003","article-title":"A perivascular origin for mesenchymal stem cells in multiple human organs","volume":"3","author":"Crisan","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.metabol.2018.10.005_bb0335","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1182\/blood-2012-08-451864","article-title":"Perivascular support of human hematopoietic stem\/progenitor cells","volume":"121","author":"Corselli","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.metabol.2018.10.005_bb0340","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/cyto.a.23242","article-title":"Isolation, cultivation, and characterization of human mesenchymal stem cells","volume":"93","author":"Mushahary","year":"2018","journal-title":"Cytometry Part A"},{"key":"10.1016\/j.metabol.2018.10.005_bb0345","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.stemcr.2016.05.011","article-title":"No identical \"Mesenchymal stem cells\" at different times and sites: human committed progenitors of distinct origin and differentiation potential are incorporated as adventitial cells in microvessels","volume":"6","author":"Sacchetti","year":"2016","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.metabol.2018.10.005_bb0350","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.cell.2006.06.044","article-title":"Matrix elasticity directs stem cell lineage specification","volume":"126","author":"Engler","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2018.10.005_bb0355","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1089\/hum.2010.136","article-title":"\"Mesenchymal\" stem cells in human bone marrow (skeletal stem cells): a critical discussion of their nature, identity, and significance in incurable skeletal disease","volume":"21","author":"Bianco","year":"2010","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.metabol.2018.10.005_bb0360","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ydbio.2017.05.001","article-title":"Pericytes are heterogeneous in their origin within the same tissue","volume":"427","author":"Dias Moura Prazeres","year":"2017","journal-title":"Dev Biol"},{"key":"10.1016\/j.metabol.2018.10.005_bb0365","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3389\/fimmu.2016.00480","article-title":"Immune regulation by pericytes: modulating innate and adaptive immunity","volume":"7","author":"Navarro","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.metabol.2018.10.005_bb0370","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF02593544","article-title":"Der Feinere Bau der Blutkapillaren","author":"Zimmermann","year":"1923","journal-title":"Z Anat Entwicklungsgesch"},{"key":"10.1016\/j.metabol.2018.10.005_bb0375","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/nn.2946","article-title":"Central nervous system pericytes in health and disease","volume":"14","author":"Winkler","year":"2011","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.metabol.2018.10.005_bb0380","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.devcel.2011.07.001","article-title":"Pericytes: developmental, physiological, and pathological perspectives, problems, and promises","volume":"21","author":"Armulik","year":"2011","journal-title":"Dev Cell"},{"key":"10.1016\/j.metabol.2018.10.005_bb0385","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/sj.jcbfm.9600214","article-title":"Angiogenic recruitment of pericytes from bone marrow after stroke","volume":"26","author":"Kokovay","year":"2006","journal-title":"Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.metabol.2018.10.005_bb0390","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nbt841","article-title":"Bone marrow-derived stem cells initiate pancreatic regeneration","volume":"21","author":"Hess","year":"2003","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.metabol.2018.10.005_bb0395","doi-asserted-by":"crossref","first-page":"17438","DOI":"10.1073\/pnas.0608249103","article-title":"Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD\/scid mice","volume":"103","author":"Lee","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2018.10.005_bb0400","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/sj.bjc.6604508","article-title":"VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma","volume":"99","author":"Beckermann","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.metabol.2018.10.005_bb0405","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cytogfr.2009.10.002","article-title":"Mechanisms involved in the therapeutic properties of mesenchymal stem cells","volume":"20","author":"da Silva","year":"2009","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.metabol.2018.10.005_bb0410","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1002\/stem.544","article-title":"Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37","volume":"28","author":"Krasnodembskaya","year":"2010","journal-title":"Stem Cells"},{"key":"10.1016\/j.metabol.2018.10.005_bb0415","doi-asserted-by":"crossref","first-page":"5303048","DOI":"10.1155\/2016\/5303048","article-title":"Antimicrobial properties of mesenchymal stem cells: therapeutic potential for cystic fibrosis infection, and treatment","volume":"2016","author":"Sutton","year":"2016","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.metabol.2018.10.005_bb0420","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1089\/ten.tea.2010.0216","article-title":"What's in a name?","volume":"16","author":"Caplan","year":"2010","journal-title":"Tissue Eng Part A"},{"key":"10.1016\/j.metabol.2018.10.005_bb0425","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ccr.2006.11.020","article-title":"A perivascular niche for brain tumor stem cells","volume":"11","author":"Calabrese","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.metabol.2018.10.005_bb0430","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001542","article-title":"Stromal endothelial cells directly influence cancer progression","volume":"3","author":"Franses","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.metabol.2018.10.005_bb0435","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/ncb2767","article-title":"The perivascular niche regulates breast tumour dormancy","volume":"15","author":"Ghajar","year":"2013","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.metabol.2018.10.005_bb0440","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1161\/hc0102.101437","article-title":"Analysis of mural cell recruitment to tumor vessels","volume":"105","author":"Abramsson","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2018.10.005_bb0445","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1172\/JCI200317929","article-title":"Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors","volume":"111","author":"Bergers","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2018.10.005_bb0450","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2018.10.005_bb0455","first-page":"1464","article-title":"Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms","volume":"61","author":"Shaheen","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.metabol.2018.10.005_bb0460","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.yexcr.2010.02.045","article-title":"Hallmarks of cancer: interactions with the tumor stroma","volume":"316","author":"Pietras","year":"2010","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.metabol.2018.10.005_bb0465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1158\/2326-6066.CIR-14-0209","article-title":"Tumors: wounds that do not heal-redux","volume":"3","author":"Dvorak","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.metabol.2018.10.005_bb0470","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/978-3-540-68976-8_12","article-title":"The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles","author":"Hall","year":"2007","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.metabol.2018.10.005_bb0475","first-page":"6335","volume":"52","author":"Young","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.metabol.2018.10.005_bb0480","doi-asserted-by":"crossref","first-page":"106","DOI":"10.18632\/oncotarget.805","article-title":"Quantification of Mesenchymal Stem Cells (MSCs) at sites of human prostate cancer","volume":"4","author":"Brennen","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.metabol.2018.10.005_bb0485","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002563","article-title":"Mesenchymal stem cells in early entry of breast cancer into bone marrow","volume":"3","author":"Corcoran","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2018.10.005_bb0490","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature06188","article-title":"Mesenchymal stem cells within tumour stroma promote breast cancer metastasis","volume":"449","author":"Karnoub","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2018.10.005_bb0495","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1002\/ijc.23431","article-title":"Bone marrow stromal cells enhance prostate cancer cell invasion through type I collagen in an MMP-12 dependent manner","volume":"122","author":"Nabha","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.metabol.2018.10.005_bb0500","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2119\/molmed.2010.00157","article-title":"Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization","volume":"17","author":"Suzuki","year":"2011","journal-title":"Mol Med"},{"key":"10.1016\/j.metabol.2018.10.005_bb0505","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1084\/jem.20051921","article-title":"Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma","volume":"203","author":"Khakoo","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.metabol.2018.10.005_bb0510","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1182\/blood-2008-09-176198","article-title":"Concentration-dependent inhibition of angiogenesis by mesenchymal stem cells","volume":"113","author":"Otsu","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.metabol.2018.10.005_bb0515","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/cr.2008.40","article-title":"Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model","volume":"18","author":"Qiao","year":"2008","journal-title":"Cell Res"},{"key":"10.1016\/j.metabol.2018.10.005_bb0520","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/14653240902807026","article-title":"Therapeutic potential of mesenchymal stromal cells in a mouse breast cancer metastasis model","volume":"11","author":"Sun","year":"2009","journal-title":"Cytotherapy"},{"key":"10.1016\/j.metabol.2018.10.005_bb0525","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/stem.559","article-title":"Concise review: dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth?","volume":"29","author":"Klopp","year":"2011","journal-title":"Stem Cells"},{"key":"10.1016\/j.metabol.2018.10.005_bb0530","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047559","article-title":"Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials","volume":"7","author":"Lalu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2018.10.005_bb0535","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.jcyt.2016.09.003","article-title":"Genetically modified mesenchymal stromal cells in cancer therapy","volume":"18","author":"Sage","year":"2016","journal-title":"Cytotherapy"},{"key":"10.1016\/j.metabol.2018.10.005_bb0540","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/SLA.0b013e3181bd62d0","article-title":"Targeting tumor stroma using engineered mesenchymal stem cells reduces the growth of pancreatic carcinoma","volume":"250","author":"Zischek","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.metabol.2018.10.005_bb0545","doi-asserted-by":"crossref","first-page":"80156","DOI":"10.18632\/oncotarget.20964","article-title":"Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells \u2014 TREAT-ME-1 \u2014 a phase I, first in human, first in class trial","volume":"8","author":"von Einem","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.metabol.2018.10.005_bb0550","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010197","article-title":"Introduction of exogenous HSV-TK suicide gene increases safety of keratinocyte-derived induced pluripotent stem cells by providing genetic \"emergency exit\" switch","volume":"19","author":"Sulkowski","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2018.10.005_bb0555","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1634\/stemcells.2007-0164","article-title":"Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation","volume":"25","author":"Karnieli","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.metabol.2018.10.005_bb0560","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3109\/14653249.2011.571248","article-title":"PDX1- and NGN3-mediated in vitro reprogramming of human bone marrow-derived mesenchymal stromal cells into pancreatic endocrine lineages","volume":"13","author":"Limbert","year":"2011","journal-title":"Cytotherapy"},{"key":"10.1016\/j.metabol.2018.10.005_bb0565","first-page":"874","article-title":"PAX4 promotes PDX1-induced differentiation of mesenchymal stem cells into insulin-secreting cells","volume":"9","author":"Xu","year":"2017","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.metabol.2018.10.005_bb0570","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3727\/096368912X647162","article-title":"Insulin-producing cells from adult human bone marrow mesenchymal stem cells control streptozotocin-induced diabetes in nude mice","volume":"22","author":"Gabr","year":"2013","journal-title":"Cell Transplant"},{"key":"10.1016\/j.metabol.2018.10.005_bb0575","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.1007\/s11033-014-3349-5","article-title":"Generation of high-yield insulin producing cells from human bone marrow mesenchymal stem cells","volume":"41","author":"Jafarian","year":"2014","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.metabol.2018.10.005_bb0580","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jbiosc.2012.02.007","article-title":"Glucose-stimulated insulin secretion of various mesenchymal stem cells after insulin-producing cell differentiation","volume":"113","author":"Kim","year":"2012","journal-title":"J Biosci Bioeng"},{"key":"10.1016\/j.metabol.2018.10.005_bb0585","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s13105-012-0228-1","article-title":"Differentiation of human adipose-derived mesenchymal stem cell into insulin-producing cells: an in vitro study","volume":"69","author":"Moshtagh","year":"2013","journal-title":"J Physiol Biochem"},{"key":"10.1016\/j.metabol.2018.10.005_bb0590","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.diff.2009.01.001","article-title":"Human bone marrow mesenchymal stem cells differentiate into insulin-producing cells upon microenvironmental manipulation in vitro","volume":"77","author":"Xie","year":"2009","journal-title":"Differentiation"},{"key":"10.1016\/j.metabol.2018.10.005_bb0595","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"Donath","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.metabol.2018.10.005_bb0600","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaut.2015.08.019","article-title":"The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes","volume":"66","author":"Pearson","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/j.metabol.2018.10.005_bb0605","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3858\/emm.2012.44.1.002","article-title":"Differentiation of human labia minora dermis-derived fibroblasts into insulin-producing cells","volume":"44","author":"Kim","year":"2012","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.metabol.2018.10.005_bb0610","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1172\/JCI200316502","article-title":"In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion","volume":"111","author":"Ianus","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2018.10.005_bb0615","doi-asserted-by":"crossref","first-page":"616","DOI":"10.2337\/diabetes.53.3.616","article-title":"No evidence for significant transdifferentiation of bone marrow into pancreatic beta-cells in vivo","volume":"53","author":"Lechner","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2018.10.005_bb0620","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/nature01539","article-title":"Transplanted bone marrow regenerates liver by cell fusion","volume":"422","author":"Vassilopoulos","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2018.10.005_bb0625","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/nature01531","article-title":"Cell fusion is the principal source of bone-marrow-derived hepatocytes","volume":"422","author":"Wang","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2018.10.005_bb0630","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nature02520","article-title":"Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation","volume":"429","author":"Dor","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2018.10.005_bb0635","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3748\/wjg.v11.i4.545","article-title":"Prevention of core cell damage in isolated islets of Langerhans by low temperature preconditioning","volume":"11","author":"Cui","year":"2005","journal-title":"World J Gastroenterol"},{"issue":"Suppl. 1","key":"10.1016\/j.metabol.2018.10.005_bb0640","first-page":"S21","article-title":"The vascular trigger of type II diabetes mellitus","volume":"116","author":"Lammert","year":"2008","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.metabol.2018.10.005_bb0645","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00125-007-0868-9","article-title":"Optimising islet engraftment is critical for successful clinical islet transplantation","volume":"51","author":"Korsgren","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2018.10.005_bb0650","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/01.RES.0000118601.37875.AC","article-title":"Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms","volume":"94","author":"Kinnaird","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2018.10.005_bb0655","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.transproceed.2008.11.015","article-title":"Bone marrow-derived mesenchymal stem cells improve islet graft function in diabetic rats","volume":"41","author":"Figliuzzi","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.metabol.2018.10.005_bb0660","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1097\/TP.0b013e3181db09c4","article-title":"Mesenchymal stem cell and islet co-transplantation promotes graft revascularization and function","volume":"89","author":"Ito","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.metabol.2018.10.005_bb0665","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/TP.0b013e3181cb3e8d","article-title":"Bone marrow cell cotransplantation with islets improves their vascularization and function","volume":"89","author":"Sakata","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.metabol.2018.10.005_bb0670","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/stem.259","article-title":"Mesenchymal cells appearing in pancreatic tissue culture are bone marrow-derived stem cells with the capacity to improve transplanted islet function","volume":"28","author":"Sordi","year":"2010","journal-title":"Stem Cells"},{"key":"10.1016\/j.metabol.2018.10.005_bb0675","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/TP.0b013e3181c7dc99","article-title":"Trophic molecules derived from human mesenchymal stem cells enhance survival, function, and angiogenesis of isolated islets after transplantation","volume":"89","author":"Park","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.metabol.2018.10.005_bb0680","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.3748\/wjg.v16.i10.1215","article-title":"Bone marrow cells produce nerve growth factor and promote angiogenesis around transplanted islets","volume":"16","author":"Sakata","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.metabol.2018.10.005_bb0685","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s00125-013-3109-4","article-title":"Mesenchymal stromal cells improve transplanted islet survival and islet function in a syngeneic mouse model","volume":"57","author":"Borg","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2018.10.005_bb0690","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117561","article-title":"The co-transplantation of bone marrow derived mesenchymal stem cells reduced inflammation in intramuscular islet transplantation","volume":"10","author":"Yoshimatsu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2018.10.005_bb0695","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1002\/jcb.23250","article-title":"Therapeutic factors secreted by mesenchymal stromal cells and tissue repair","volume":"112","author":"Lee","year":"2011","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.metabol.2018.10.005_bb0700","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.mce.2018.01.024","article-title":"Mesenchymal stem cell (MSC)-mediated survival of insulin producing pancreatic beta-cells during cellular stress involves signalling via Akt and ERK1\/2","volume":"473","author":"Liu","year":"2018","journal-title":"Mol Cell Endocrinol"},{"issue":"Suppl. 2","key":"10.1016\/j.metabol.2018.10.005_bb0705","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1463-1326.2007.00783.x","article-title":"Regulation of beta-cell mass and function by the Akt\/protein kinase B signalling pathway","volume":"9","author":"Elghazi","year":"2007","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.metabol.2018.10.005_bb0710","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/ncb1005","article-title":"Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK","volume":"5","author":"Allan","year":"2003","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.metabol.2018.10.005_bb0715","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ccr.2005.09.006","article-title":"The BAD protein integrates survival signaling by EGFR\/MAPK and PI3K\/Akt kinase pathways in PTEN-deficient tumor cells","volume":"8","author":"She","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.metabol.2018.10.005_bb0720","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1634\/stemcells.2006-0686","article-title":"Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis","volume":"25","author":"Hung","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.metabol.2018.10.005_bb0725","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/19382014.2017.1286434","article-title":"Effect of co-culture of mesenchymal stem\/stromal cells with pancreatic islets on viability and function outcomes: a systematic review and meta-analysis","volume":"9","author":"de Souza","year":"2017","journal-title":"Islets"},{"key":"10.1016\/j.metabol.2018.10.005_bb0730","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jcyt.2012.11.008","article-title":"Pre-culturing islets with mesenchymal stromal cells using a direct contact configuration is beneficial for transplantation outcome in diabetic mice","volume":"15","author":"Rackham","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.metabol.2018.10.005_bb0735","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3727\/215517914X680047","article-title":"Preculturing islets with adipose-derived mesenchymal stromal cells is an effective strategy for improving transplantation efficiency at the clinically preferred intraportal site","volume":"7","author":"Rackham","year":"2014","journal-title":"Cell medicine"},{"key":"10.1016\/j.metabol.2018.10.005_bb0740","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2337\/db15-0990","article-title":"Annexin A1 is a key modulator of mesenchymal stromal cell-mediated improvements in islet function","volume":"65","author":"Rackham","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2018.10.005_bb0745","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1134\/S1607672918020047","article-title":"The differential expression of adhesion molecule and extracellular matrix genes in mesenchymal stromal cells after interaction with cord blood hematopoietic progenitors","volume":"479","author":"Buravkova","year":"2018","journal-title":"Dokl Biochem Biophys"},{"key":"10.1016\/j.metabol.2018.10.005_bb0750","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s00125-017-4524-8","article-title":"Extracellular matrix molecules and their potential contribution to the function of transplanted pancreatic islets","volume":"61","author":"Llacua","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2018.10.005_bb0755","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.placenta.2017.04.003","article-title":"Immunomodulatory properties of human placental mesenchymal stem\/stromal cells","volume":"59","author":"Abumaree","year":"2017","journal-title":"Placenta"},{"key":"10.1016\/j.metabol.2018.10.005_bb0760","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.2337\/db09-0317","article-title":"Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9","volume":"58","author":"Ding","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2018.10.005_bb0765","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1038\/mt.2013.147","article-title":"Third-party mesenchymal stem cells improved human islet transplantation in a humanized diabetic mouse model","volume":"21","author":"Wu","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.metabol.2018.10.005_bb0770","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.2337\/db10-0136","article-title":"Mesenchymal stem cells enhance allogeneic islet engraftment in nonhuman primates","volume":"59","author":"Berman","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2018.10.005_bb0775","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s00125-009-1374-z","article-title":"Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells","volume":"52","author":"Madec","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2018.10.005_bb0780","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.2337\/db10-0542","article-title":"Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes","volume":"59","author":"Jurewicz","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2018.10.005_bb0785","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004226","article-title":"Human cord blood stem cell-modulated regulatory T lymphocytes reverse the autoimmune-caused type 1 diabetes in nonobese diabetic (NOD) mice","volume":"4","author":"Zhao","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2018.10.005_bb0790","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1741-7015-10-3","article-title":"Reversal of type 1 diabetes via islet beta cell regeneration following immune modulation by cord blood-derived multipotent stem cells","volume":"10","author":"Zhao","year":"2012","journal-title":"BMC Med"},{"key":"10.1016\/j.metabol.2018.10.005_bb0795","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/1741-7015-11-160","article-title":"Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I\/II clinical trial","volume":"11","author":"Zhao","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.metabol.2018.10.005_bb0800","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jcyt.2015.04.001","article-title":"In vitro characterization of human hair follicle dermal sheath mesenchymal stromal cells and their potential in enhancing diabetic wound healing","volume":"17","author":"Ma","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/j.metabol.2018.10.005_bb0805","first-page":"2795","article-title":"A role for pericytes as microenvironmental regulators of human skin tissue regeneration","volume":"119","author":"Paquet-Fifield","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2018.10.005_bb0810","doi-asserted-by":"crossref","first-page":"6901983","DOI":"10.1155\/2018\/6901983","article-title":"Mesenchymal stromal cells and cutaneous wound healing: a comprehensive review of the background, role, and therapeutic potential","volume":"2018","author":"Hu","year":"2018","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.metabol.2018.10.005_bb0815","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1089\/wound.2014.0539","article-title":"The effect of bone-marrow-derived stem cells and adipose-derived stem cells on wound contraction and epithelization","volume":"3","author":"Uysal","year":"2014","journal-title":"Adv Wound Care"},{"key":"10.1016\/j.metabol.2018.10.005_bb0820","article-title":"Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing","volume":"3","author":"Chen","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2018.10.005_bb0825","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jdermsci.2007.05.018","article-title":"Wound healing effect of adipose-derived stem cells: a critical role of secretory factors on human dermal fibroblasts","volume":"48","author":"Kim","year":"2007","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.metabol.2018.10.005_bb0830","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1524-475X.2009.00499.x","article-title":"Hypoxia-enhanced wound-healing function of adipose-derived stem cells: increase in stem cell proliferation and up-regulation of VEGF and bFGF","volume":"17","author":"Lee","year":"2009","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.metabol.2018.10.005_bb0835","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/wrr.12415","article-title":"Pericytes: a newly recognized player in wound healing","volume":"24","author":"Bodnar","year":"2016","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.metabol.2018.10.005_bb0840","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12929-018-0423-7","article-title":"Molecular mechanisms underlying therapeutic potential of pericytes","volume":"25","author":"Harrell","year":"2018","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.metabol.2018.10.005_bb0845","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1524-475X.2007.00237.x","article-title":"Enhanced epithelial gap closure and increased angiogenesis in wounds of diabetic mice treated with adult murine bone marrow stromal progenitor cells","volume":"15","author":"Javazon","year":"2007","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.metabol.2018.10.005_bb0850","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jdiacomp.2014.05.003","article-title":"Mesenchymal stem cells ameliorate impaired wound healing through enhancing keratinocyte functions in diabetic foot ulcerations on the plantar skin of rats","volume":"28","author":"Kato","year":"2014","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.metabol.2018.10.005_bb0855","doi-asserted-by":"crossref","first-page":"R109","DOI":"10.1530\/JME-17-0117","article-title":"Therapeutic potential of mesenchymal stem cells for diabetes","volume":"59","author":"Moreira","year":"2017","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.metabol.2018.10.005_bb0860","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0301-472X(03)00110-3","article-title":"HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells","volume":"31","author":"Le Blanc","year":"2003","journal-title":"Exp Hematol"},{"key":"10.1016\/j.metabol.2018.10.005_bb0865","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1111\/j.1582-4934.2011.01509.x","article-title":"Immunogenicity of allogeneic mesenchymal stem cells","volume":"16","author":"Schu","year":"2012","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.metabol.2018.10.005_bb0870","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.2337\/dc14-2830","article-title":"Allogeneic mesenchymal precursor cells in type 2 diabetes: a randomized, placebo-controlled, dose-escalation safety and tolerability pilot study","volume":"38","author":"Skyler","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2018.10.005_bb0875","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jcyt.2015.03.608","article-title":"Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow-derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus","volume":"17","author":"Thakkar","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/j.metabol.2018.10.005_bb0880","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10238-013-0266-1","article-title":"Novel therapy for insulin-dependent diabetes mellitus: infusion of in vitro-generated insulin-secreting cells","volume":"15","author":"Dave","year":"2015","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.metabol.2018.10.005_bb0885","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3727\/096368915X689622","article-title":"Clinical trials with mesenchymal stem cells: an update","volume":"25","author":"Squillaro","year":"2016","journal-title":"Cell Transplant"},{"key":"10.1016\/j.metabol.2018.10.005_bb0890","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1007\/s00125-005-1949-2","article-title":"Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration?","volume":"48","author":"Meier","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2018.10.005_bb0895","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2337\/db14-0656","article-title":"Preserved beta-cell function in type 1 diabetes by mesenchymal stromal cells","volume":"64","author":"Carlsson","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2018.10.005_bb0900","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1507\/endocrj.EJ12-0343","article-title":"Long term effects of the implantation of Wharton's jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus","volume":"60","author":"Hu","year":"2013","journal-title":"Endocr J"},{"key":"10.1016\/j.metabol.2018.10.005_bb0905","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/sctm.17-0139","article-title":"Autologous mesenchymal stem cell and islet cotransplantation: safety and efficacy","volume":"7","author":"Wang","year":"2018","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.metabol.2018.10.005_bb0910","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.3892\/etm.2016.3544","article-title":"Long term effect and safety of Wharton's jelly-derived mesenchymal stem cells on type 2 diabetes","volume":"12","author":"Hu","year":"2016","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.metabol.2018.10.005_bb0915","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11684-011-0116-z","article-title":"Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study","volume":"5","author":"Jiang","year":"2011","journal-title":"Frontiers of medicine"},{"key":"10.1016\/j.metabol.2018.10.005_bb0920","doi-asserted-by":"crossref","first-page":"6901286","DOI":"10.1155\/2016\/6901286","article-title":"Umbilical cord as prospective source for mesenchymal stem cell-based therapy","volume":"2016","author":"Arutyunyan","year":"2016","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.metabol.2018.10.005_bb0925","doi-asserted-by":"crossref","first-page":"6810980","DOI":"10.1155\/2016\/6810980","article-title":"Standardizing umbilical cord mesenchymal stromal cells for translation to clinical use: selection of GMP-compliant medium and a simplified isolation method","volume":"2016","author":"Smith","year":"2016","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.metabol.2018.10.005_bb0930","doi-asserted-by":"crossref","first-page":"1750697","DOI":"10.1155\/2016\/1750697","article-title":"Manufacturing cells for clinical use","volume":"2016","author":"Weiss","year":"2016","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.metabol.2018.10.005_bb0935","doi-asserted-by":"crossref","first-page":"8024","DOI":"10.1038\/ncomms9024","article-title":"p75(NTR)-dependent activation of NF-kappaB regulates microRNA-503 transcription and pericyte-endothelial crosstalk in diabetes after limb ischaemia","volume":"6","author":"Caporali","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2018.10.005_bb0940","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s12015-018-9809-x","article-title":"Dysfunction of mesenchymal stem cells isolated from metabolic syndrome and type 2 diabetic patients as result of oxidative stress and autophagy may limit their potential therapeutic use","volume":"14","author":"Kornicka","year":"2018","journal-title":"Stem Cell Rev"},{"key":"10.1016\/j.metabol.2018.10.005_bb0945","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00441-013-1630-x","article-title":"Effect of isolation methodology on stem cell properties and multilineage differentiation potential of human dental pulp stem cells","volume":"353","author":"Hilkens","year":"2013","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.metabol.2018.10.005_bb0950","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11626-011-9480-x","article-title":"Comparison of different methods for the isolation of mesenchymal stem cells from human umbilical cord Wharton's jelly","volume":"48","author":"Salehinejad","year":"2012","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"10.1016\/j.metabol.2018.10.005_bb0955","doi-asserted-by":"crossref","first-page":"428726","DOI":"10.1155\/2013\/428726","article-title":"Comparison of explant-derived and enzymatic digestion-derived MSCs and the growth factors from Wharton's jelly","volume":"2013","author":"Yoon","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.metabol.2018.10.005_bb0960","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2018.10.005_bb0965","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","article-title":"Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6","volume":"5","author":"Lee","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.metabol.2018.10.005_bb0970","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1182\/blood-2007-12-128702","article-title":"The CD34-like protein PODXL and alpha6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice","volume":"113","author":"Lee","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.metabol.2018.10.005_bb0975","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.metabol.2018.10.005_bb0980","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/med.21322","article-title":"The gap between the physiological and therapeutic roles of mesenchymal stem cells","volume":"34","author":"Galderisi","year":"2014","journal-title":"Med Res Rev"},{"key":"10.1016\/j.metabol.2018.10.005_bb0985","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nm.3028","article-title":"The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine","volume":"19","author":"Bianco","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2018.10.005_bb2005","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1089\/scd.2016.0275","article-title":"Efficacy of autologous bone marrow-derived mesenchymal stem cell and mononuclear cell transplantation in type 2 diabetes mellitus: a randomized, placebo-controlled comparative study","volume":"26","author":"Bhansali","year":"2017","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.metabol.2018.10.005_bb2010","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2337\/dc15-0171","article-title":"Umbilical cord mesenchymal stromal cell with autologous bone marrow cell transplantation in established type 1 diabetes: a pilot randomized controlled open-label clinical study to assess safety and impact on insulin secretion","volume":"39","author":"Cai","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2018.10.005_bb2015","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.3892\/etm.2015.2339","article-title":"Therapeutic efficacy of umbilical cord-derived mesenchymal stem cells in patients with type 2 diabetes","volume":"9","author":"Guan","year":"2015","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.metabol.2018.10.005_bb2020","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.7754\/Clin.Lab.2014.140305","article-title":"Umbilical cord mesenchymal stem cell transfusion ameliorated hyperglycemia in patients with type 2 diabetes mellitus","volume":"60","author":"Kong","year":"2014","journal-title":"Clin Lab"},{"key":"10.1016\/j.metabol.2018.10.005_bb2025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/scrt446","article-title":"A preliminary evaluation of efficacy and safety of Wharton's jelly mesenchymal stem cell transplantation in patients with type 2 diabetes mellitus","volume":"5","author":"Liu","year":"2014","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.metabol.2018.10.005_bb2030","doi-asserted-by":"crossref","first-page":"582382","DOI":"10.4061\/2010\/582382","article-title":"Cotransplantation of adipose tissue-derived insulin-secreting mesenchymal stem cells and hematopoietic stem cells: a novel therapy for insulin-dependent diabetes mellitus","volume":"2010","author":"Vanikar","year":"2010","journal-title":"Stem Cells Int"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049518302154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049518302154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:18:31Z","timestamp":1758428311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049518302154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":203,"alternative-id":["S0026049518302154"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2018.10.005","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stem cells in the treatment of diabetes mellitus \u2014 Focus on mesenchymal stem cells","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2018.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}